NCCN 腫瘍学臨床実践ガイドライン がん関連感染 …

1 NCCN 2008 1 2008 1 Guidelines Index Prevention/Treatment Infection TOC MS, References NCCN *Brahm H. Segal, MD/Co-Chair Roswell Park Cancer Institute *Lindsey Robert Baden, MD/Co-Chair Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center Arthur E. Brown, MD Memorial Sloan-Kettering Cancer Center Corey Casper, MD, MPH Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance Erik Dubberke, MD Siteman Cancer Center at Barnes- Jewish Hospital and Washington University School of Medicine Alison G.

2 Freifeld, MD UNMC Eppley Cancer Center at The Nebraska Medical Center Michael Gelfand, MD St. Jude Children's Research Hospital/University of Tennessee Cancer Institute John N. Greene, MD H. Lee Moffitt Cancer Center & Research Institute Michael G. Ison, MD, MS Robert H. Lurie Comprehensive Cancer Center at Northwestern University James I. Ito, MD City of Hope Judith E. Karp, MD The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Daniel R. Kaul, MD University of Michigan Comprehensive Cancer Center Earl King, MD Fox Chase Cancer Center Emily Mackler, PharmD University of Michigan Comprehensive Cancer Center Guido Marcucci, MD Arthur G.

3 James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University Jose G. Montoya, MD Stanford Comprehensive Cancer Center Ashley Morris-Engemann, PharmD Duke Comprehensive Cancer Center Ken Rolston, MD The University of Texas Anderson Cancer Center Angelina S. The, MD University of Alabama at Birmingham Comprehensive Cancer Center / * 2008 1 2008 1 16 2008 National Comprehensive Cancer Network, Inc. NCCN 2008 1 Guidelines Index Prevention/Treatment Infection TOC MS.

4 References NCCN INF-1 INF-2 INF-3 INF-4 INF-5 INF-6 FEV-1 FEV-2 FEV-3 z / FEV-4 z FEV-5 z FEV-6 z FEV-7 FEV-8 FEV-9 FEV-12 FEV-13 FEV-A FEV-B FEV-C FEV-D FEV-E FEV-F NCCN NCCN NCCN 2A NCCN NCCN 2008 2008 1 2008 1 16 2008 National Comprehensive Cancer Network, Inc.

5 NCCN 2008 1 2008 1 2008 1 16 2008 National Comprehensive Cancer Network, Inc. NCCN 2A NCCN Guidelines Index Prevention/Treatment Infection TOC MS, References NCCN NCCN graft versus host disease GVHD hematopoietic stem cell transplant HSCT NCCN

6 NCCN HSCT GVHD NCCN CT UPDATES 2008 1 Guidelines Index Prevention/Treatment Infection TOC MS, References INF-1 2008 1 2008 1 16 2008 National Comprehensive Cancer Network, Inc.

7 NCCN 2A NCCN a / FEV-3 b,c,d,e z z 7 z z z HSV z HSCT z z z CLL z 2-CdA z 7 10 z z z HSCT 30 z HSCT z z z GVHD z 10 z z INF-3 z HSCT 30 2-CdA CLL CMV GVHD HSCT HSV VZV a

8 B INF-5 c / FEV-A /d FEV-B e / FEV-C 2008 1 2008 1 2008 1 16 2008 National Comprehensive Cancer Network, Inc. NCCN Guidelines Index Prevention/Treatment Infection TOC MS, References a / c z z 7 f z HSCT z z CLL z z z 7 10 f z HSCT z z MDS z 10 GVHD TMP/SMX TMP/SMX 2 CD4 200/mcL a c / FEV-A f 2A

9 NCCN INF-2 2008 1 2008 1 2008 1 16 2008 National Comprehensive Cancer Network, Inc. NCCN Guidelines Index Prevention/Treatment Infection TOC MS, References a / d ALL MDS AML HSCT HSCT GVHDg h z i z B j 2B z 1 z 2B z B j 2B z 1 z 1 2B z 1 z 1 z 1 z 2B z 1 z B j 2B z 1 z 2B z 2B z B j 2B

10 75 GVHD a /d FEV-B g GVHD h i P450A j 2A NCCN INF-3 2008 1 2008 1 2008 1 16 2008 National Comprehensive Cancer Network, Inc. NCCN Guidelines Index Prevention/Treatment Infection TOC MS.